Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast

Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast

Objective. Idiopathic inflammatory myopathies (IIM) are rare autoimmune diseases that primarily affect striated muscles; skin, joints, and lungs may be involved with different degrees of severity. Traditional treatment relies on high-dose glucocorticoids and conventional synthetic disease-modifying...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Chiara Rizzo, Silvia Grazzini, Edoardo Conticini, Hector Chinoy, Roberto D’Alessandro, Federica Camarda, Luca Cantarini, Bruno Frediani, Giuliana Guggino, Lidia La Barbera
Formatua: Artikulua
Hizkuntza:English
Argitaratua: PAGEPress Publications 2025-01-01
Saila:Reumatismo
Gaiak:
Idiopathic inflammatory myopathies
myositis
treatment
JAK inhibitors
apremilast
tsDMARDs
Sarrera elektronikoa:https://www.reumatismo.org/reuma/article/view/1718

Internet

https://www.reumatismo.org/reuma/article/view/1718

Antzeko izenburuak